NCT03472469 - MAST Trial: Multi-modal Analgesic Strategies in Trauma | Biotech Hunter

Enrollment

1,561

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

July 3, 2019

Study Completion Date

July 3, 2019

Conditions

Nonspecific Pain Post Traumatic Injury

Interventions

DRUG

Acetaminophen IV/PO

Acetaminophen 1g IV/PO every 6 hours

DRUG

Acetaminophen PO

Acetaminophen 1g PO every 6 hours

DRUG

Ketorolac

Ketorolac 30mg IV once

DRUG

Celebrex

Celebrex 200mg PO every 12 hours

DRUG

Naproxen

Naproxen 500mg PO every 12 hours

DRUG

Tramadol

Tramadol 100mg PO every 6 hours

DRUG

Pregabalin

Pregabalin 100mg PO every 8 hours

DRUG

Gabapentin

Gabapentin 300mg PO every 8 hours

DRUG

Lidocaine

Lidocaine patch every 12 hours

DRUG

Opioids

Opioid options include: Oral Opioids (Codeine, Tramadol, Hydrocodone, Oxycodone, Methadone, Morphine, Hydromorphone); Transdermal Opioid (Fentanyl); Intravenous Opioids (Morphine, Hydromorphone, Fentanyl)

DRUG

Regional anesthesia

Trial Locations (1)

77030

The University of Texas Health Science Center at Houston, Houston

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

The University of Texas Health Science Center, Houston

OTHER